Data Sheet 1_Prevalence and risk factors of herpes zoster in patients with rheumatoid arth

Shuo Wang's 2026 meta-analysis on figshare aggregates data from 17 observational studies comprising 472,150 patients to assess herpes zoster (HZ) prevalence and risk factors in rheumatoid arthritis (RA) populations. The analysis reports a pooled HZ proportion of 6% and identifies 11 significant associated factors, including demographics, medication use, and comorbidities. The dataset is shared under a CC-BY-4.0 license.

Use Cases

• Estimating the pooled prevalence of herpes zoster in rheumatoid arthritis patients based on the reported 6% proportion.
• Modeling risk factors for herpes zoster based on identified variables like gender, age, and corticosteroid dosage.
• Comparing the effect sizes of different medications (e.g., TNF inhibitors, methotrexate) on herpes zoster risk using the reported odds ratios.
• Assessing the impact of comorbidities (e.g., pulmonary disease, hypertension) on infection risk in autoimmune patients.

Strengths

• Aggregates data from 472,150 patients across 17 studies, providing a substantial evidence base.
• Reports specific odds ratios and confidence intervals for 11 evaluated risk factors.
• Follows PRISMA guidelines and uses the Newcastle-Ottawa Scale for quality assessment.

Limitations

• Row count is unknown, which may limit suitability assessment.
• Column-level documentation is absent; field semantics must be inferred after download.
• The 95% prediction interval for HZ prevalence (5% to 45%) indicates substantial heterogeneity across studies.

Provenance

Source

figshare, author Shuo Wang.

Collection Method

Systematic review and meta-analysis of literature from eight databases (PubMed, Web of Science, etc.).

Time Range

null

Freshness

Last updated 2026-05 08 05:40:35; freshness should be verified.

Geography

null